ZW191, a FRα-targeted topoisomerase 1 inhibitor ADC with a differentiated antitumor efficacy and tolerability profile
1. 文件大小不能超过300M, 允许上传文档或压缩包等
2. 请确保上传文献的真实性、完整性,不得对原文做任何修改
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1158/1078-0432.CCR-25-4691
其他信息:
出版社: American Association for Cancer Research (AACR)
作者: Samuel Lawn; Andrea Hernandez Rojas; Jodi Wong; Lemlem Degefie; Araba Sagoe-Wagner; Ambroise Wu; Allysha Bissessur; Matthew Bonderud; Kaylee Wu; Diego Alonzo; Samir Das; Peter Chan; Vincent Fung; Luying Yang; Geoffrey C. Winters; Kurt Stahl; Dunja Urosev; Kari Frantzen; Paul A. Moore; Raffaele Colombo; Stuart D. Barnscher; Jamie R. Rich
全文下载地址: https://aacrjournals.org/clincancerres/article-pdf/doi/10.1158/1078-0432.CCR-25-4691/3765652/ccr-25-4691.pdf

